Kemnay Advisory Services’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $64.3K | Buy |
2,291
+24
| +1% | +$639 | 0.01% | 201 |
|
|
2025
Q4 | $56.4K | Buy |
+2,267
| New | +$57.2K | 0.01% | 290 |
|
|
2021
Q4 | – | Sell |
-1,500
| Closed | -$65K | – | 67 |
|
|
2021
Q3 | $65K | Hold |
1,500
| – | – | 0.01% | 81 |
|
|
2021
Q2 | $59K | Hold |
1,500
| – | – | 0.01% | 87 |
|
|
2021
Q1 | $54K | Hold |
1,500
| – | – | 0.01% | 82 |
|
|
2020
Q4 | $55K | Sell |
1,500
-81
| -5% | -$2.97K | 0.01% | 88 |
|
|
2020
Q3 | $55K | Hold |
1,581
| – | – | 0.01% | 76 |
|
|
2020
Q2 | $49K | Hold |
1,581
| – | – | 0.01% | 80 |
|
|
2020
Q1 | $49K | Hold |
1,581
| – | – | 0.01% | 61 |
|
|
2019
Q4 | $59K | Hold |
1,581
| – | – | 0.01% | 61 |
|
|
2019
Q3 | $54K | Hold |
1,581
| – | – | 0.01% | 69 |
|
|
2019
Q2 | $65K | Hold |
1,581
| – | – | 0.02% | 54 |
|
|
2019
Q1 | $64K | Hold |
1,581
| – | – | 0.01% | 119 |
|
|
2018
Q4 | $65K | Hold |
1,581
| – | – | 0.02% | 110 |
|
|
2018
Q3 | $66K | Hold |
1,581
| – | – | 0.02% | 113 |
|
|
2018
Q2 | $54K | Hold |
1,581
| – | – | 0.02% | 117 |
|
|
2018
Q1 | $53K | Hold |
1,581
| – | – | 0.02% | 97 |
|
|
2017
Q4 | $54K | Hold |
1,581
| – | – | 0.02% | 97 |
|
|
2017
Q3 | $54K | Hold |
1,581
| – | – | 0.02% | 96 |
|
|
2017
Q2 | $50K | Hold |
1,581
| – | – | 0.03% | 99 |
|
|
2017
Q1 | $51K | Hold |
1,581
| – | – | 0.03% | 38 |
|
|
2016
Q4 | $49K | Hold |
1,581
| – | – | 0.04% | 37 |
|
|
2016
Q3 | $51K | Hold |
1,581
| – | – | 0.04% | 34 |
|
|
2016
Q2 | $53K | Hold |
1,581
| – | – | 0.04% | 32 |
|
|
2016
Q1 | $44K | Hold |
1,581
| – | – | 0.03% | 37 |
|
|
2015
Q4 | $48K | Hold |
1,581
| – | – | 0.03% | 36 |
|
|
2015
Q3 | $47K | Hold |
1,581
| – | – | 0.04% | 37 |
|
|
2015
Q2 | $50K | Hold |
1,581
| – | – | 0.04% | 29 |
|
|
2015
Q1 | $52K | Hold |
1,581
| – | – | 0.03% | 31 |
|
|
2014
Q4 | $47K | Hold |
1,581
| – | – | 0.02% | 36 |
|
|
2014
Q3 | $44K | Sell |
1,581
-287,742
| -99% | -$8.08M | 0.03% | 46 |
|
|
2014
Q2 | $8.15M | Buy |
289,323
+1,581
| +0.5% | +$45.1K | 2.96% | 14 |
|
|
2014
Q1 | $8.77M | Hold |
287,742
| – | – | 4.41% | 9 |
|
|
2013
Q4 | $8.36M | Sell |
287,742
-130,032
| -31% | -$3.78M | 5.95% | 10 |
|
|
2013
Q3 | $11.4M | Sell |
417,774
-157,710
| -27% | -$4.29M | 8.79% | 3 |
|
|
2013
Q2 | $15.3M | Buy |
+575,484
| New | +$15.9M | 7.23% | 6 |
|
Other funds holding PFE
VCM
VPM
Kemnay Advisory Services's PFE Position: Q1 2026 in Review
Kemnay Advisory Services increased its Pfizer (PFE) stake by 1.1% in Q1 2026, buying an estimated $639 and bringing the position to 2,291 shares worth $64.3K. The position accounts for 0.01% of the portfolio, ranked #201.
Kemnay Advisory Services first reported a position in PFE in Q2 2013 and has held it in 36 quarters since. The position peaked at $15.3M in Q2 2013. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Kemnay Advisory Services held 2,291 shares of Pfizer worth $64.3K as of Q1 2026.
- Kemnay Advisory Services bought 24 Pfizer shares in Q1 2026, an estimated $639.
- Pfizer made up 0.01% of Kemnay Advisory Services's portfolio in Q1 2026, its #201 holding.
- Kemnay Advisory Services first reported a position in Pfizer in Q2 2013 and has held it in 36 quarters since.
- Kemnay Advisory Services's Pfizer position peaked at $15.3M in Q2 2013.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Kemnay Advisory Services's 13F filing for Q1 2026, filed 15 May 2026.